1998
DOI: 10.1021/bi972773e
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Calmodulin-Activated Smooth-Muscle Myosin Light-Chain Kinase by Calmodulin-Binding Peptides and Fluorescent (Phosphodiesterase-Activating) Calmodulin Derivatives

Abstract: Aspects of the biochemistry of calmodulin have been addressed that bear on its cell biological role as a mediator of Ca2+ regulation. Calmodulin-binding peptides derived from the amino acid sequence of smooth-muscle myosin light-chain kinase (MLCK) were characterized as inhibitors of calmodulin activation of MLCK-catalyzed phosphorylation of the smooth-muscle regulatory light chain (MLC). MLCK activity was determined by measuring the rate of formation of one of the reaction products, ADP, in a coupled enzymati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
35
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(37 citation statements)
references
References 40 publications
2
35
0
Order By: Relevance
“…1H). The previously described Trp peptide (Török and Trentham, 1994;Török et al, 1998a;Török et al, 1998b) was myristoylated at the N-terminus to make it membrane permeant. The Ca 2+ /CaM-binding properties of mTrp peptide were determined by stopped-flow fluorimetry using TA-CaM.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…1H). The previously described Trp peptide (Török and Trentham, 1994;Török et al, 1998a;Török et al, 1998b) was myristoylated at the N-terminus to make it membrane permeant. The Ca 2+ /CaM-binding properties of mTrp peptide were determined by stopped-flow fluorimetry using TA-CaM.…”
Section: Resultsmentioning
confidence: 99%
“…A cell permeant CaM-binding peptide based on the acetylated Trp peptide (Ac-RRKWQKTGHAVRAIGRL-CONH 2 ) (Török and CaM nuclear translocation Trentham, 1994;Török et al, 1998a;Török et al, 1998b) was generated by N-terminal myristoylation instead of acetylation. This myristoylated peptide (mTrp) was HPLC-purified to homogeneity and its K d for 2-chloro-(ε-amino-Lys75) [6-4-(N,N-diethhylamino)phenyl]-1,3,5-triazin-4-yl-CaM (TA-CaM) was determined by stopped-flow kinetic experiments in a Hi-Tech PQ/SF-51MX multimixing stoppedflow spectrofluorimeter (Hi-Tech Scientific, UK) in the solution conditions above with the exception of EGTA being replaced by 100 µM CaCl 2 .…”
Section: Peptide Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Scheme 1 was therefore modified to include k 1 : The system of rate equations for Scheme 3 (see eq S13 in the Supporting Information) yielded further conditions for the kinetic rate constants. The fluorescence experiment reported here lacked the time resolution to directly measure k 1 , which has been reported for various enzymes to be on the order of 10 8 M −1 s −1 (14,15,30). Caride and co-workers recently analyzed CaM binding to the CaM binding domain of isoform 4b of PMCA (14,15).…”
Section: Kinetic Modelingmentioning
confidence: 99%
“…1 and 3. In a previous characterization of MLCK-P ("Trp peptide"), the K d value of calmodulin and MLCK-P was calculated to be 6 pM from assay of MLCK inhibition, yielding the conclusion that the peptide inhibits MLCK by trapping calmodulin and leaving free calmodulin concentrations very low (23). Similarly, prior characterization of CaMKII-P ("peptide 290 -309") determined that CaMKII-P inhibits CaMKII and CaM-dependent phosphodiesterase activity by peptide interaction with CaM and not by a direct effect on the enzyme (24).…”
Section: Methodsmentioning
confidence: 99%